FINDRISC Demonstrated Good Rule-Out Performance in Severe Obesity Tags ORAL GTT hBA1c Read more about FINDRISC Demonstrated Good Rule-Out Performance in Severe Obesity
Orforglipron Demonstrated Dose-Dependent GI Adverse Events Tags GLP-1 agonists Read more about Orforglipron Demonstrated Dose-Dependent GI Adverse Events
SGLT2 Inhibitors Not Linked to Higher UTI Risk After Ileal Urinary Diversion Tags Diabetic Nephropathy SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Not Linked to Higher UTI Risk After Ileal Urinary Diversion
Machine Learning Identified Microbial Signatures Associated With T1DM Read more about Machine Learning Identified Microbial Signatures Associated With T1DM
Vitamin C Levels Inversely Associated With DR Risk Tags Retinopathy Read more about Vitamin C Levels Inversely Associated With DR Risk
RT-Based Exercise Improved Vascular Function in T2DM Read more about RT-Based Exercise Improved Vascular Function in T2DM
Urinary Podocalyxin Demonstrated Strong DKD Discrimination in T1DM Tags Diabetic Nephropathy Read more about Urinary Podocalyxin Demonstrated Strong DKD Discrimination in T1DM
Orforglipron Shows Dose-Related GI Adverse Events Tags GLP-1 agonists Read more about Orforglipron Shows Dose-Related GI Adverse Events
ECO 2026: Meta-Analysis Links Obesity Drugs to Lower Blood Pressure Tags Hypertension GLP-1 agonists Read more about ECO 2026: Meta-Analysis Links Obesity Drugs to Lower Blood Pressure
ECO 2026: Women Using Semaglutide Showed Reduced Triptan Use Tags GLP-1 agonists Read more about ECO 2026: Women Using Semaglutide Showed Reduced Triptan Use
